Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis
- Conditions
- Chronic Sinusitis
- Interventions
- Device: Saline irrigationDevice: Photodisinfection (antimicrobial photodynamic therapy, aPDT)
- Registration Number
- NCT01854619
- Lead Sponsor
- Ondine Biomedical Inc.
- Brief Summary
The purpose of this study is to determine whether the use of light and a topically applied photosensitizer can relieve symptoms and clinically improve patients with chronic rhinosinusitis.
- Detailed Description
This clinical trial will be a prospective, randomized, single-center study utilizing two treatment assignments and a control group. The study is expected to enroll a total of 48 subjects. The intent of the study is to evaluate a single versus double treatment of photodisinfection in men and women suffering from chronic persistent rhinosinusitis with and without nasal polyposis. Each photodisinfection treatment group will be compared to a control group receiving saline irrigation.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 48
- history of chronic rhinosinusitis with and without nasal polyposis
- no antibiotics within 4 weeks
- no oral steroid use within 4 weeks
- no topical steroid use within 2 weeks
- endoscopic sinus surgery greater than 6 months previously
- acute respiratory infection within last 2 weeks
- septal deviation restricting sinus access
- known allergy to methylene blue
- pregnant or breast feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Saline irrigation Saline irrigation Saline irrigation via syringe will be administered using a sinus irrigation catheter under endoscopic control. Double photodisinfection treatment Photodisinfection (antimicrobial photodynamic therapy, aPDT) Patients in the double treatment arm will receive a second photodisinfection treatment 4 weeks following the first treatment with regular follow-up visits Single photodisinfection treatment Photodisinfection (antimicrobial photodynamic therapy, aPDT) The single-treatment group will receive a single photodisinfection treatment of all involved paranasal sinuses with multiple follow-up visits.
- Primary Outcome Measures
Name Time Method SNOT-22 6 months The Sino-Nasal Outcome Test (SNOT-22) has been widely adopted in clinical practice and has been proved to be the most suitable and validated sinonasal outcome scoring system. The SNOT-22 is a disease-specific, quality-of-life-related measure of sinonasal function. Low score indicates good outcome.
- Secondary Outcome Measures
Name Time Method Microbiome evaluation 6 months Microbiological conventional cultures, gene expression profiling and microbiome profiling by 16s RNA.
Trial Locations
- Locations (1)
Centre hospitalier de l'UdeM (CHUM)
🇨🇦Montreal, Quebec, Canada